1-3 of 3
Giorgina Specchia, Pr, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study

Francesca Romana Mauro, MD PhD, Francesco Zaja, Stefano Molica, MD, Marta Coscia, MD PhD, Anna Marina Liberati, Alfonso Piciocchi, Fiorella Ilariucci, MD, Filomena Russo, MD, Francesca Re, MD, Alessandra Tedeschi, MD, Anna Baraldi, MD, Angelo Michele Carella, Alessandro Gozzetti, MD, Giovanni Del Poeta, Pr, MD, Agostino Cortelezzi, MD, Roberta Battistini, MD, Emilia Iannella, MD, Antonietta Ferretti, MD, Ilaria Del Giudice, MD PhD, Irene Della Starza, PhD, Sara Raponi, PhD, Maria Stefania De Propris, PhD, Caterina Ilari, PhD, Luciana Cafforio, PhD, Mauro Nanni, PhD, Paola Fazi, Marco Vignetti, Antonino Neri, Pr, MD, Giorgina Specchia, Pr, MD, Antonio Cuneo, Pr, MD, Anna Guarini, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 2946.
https://doi.org/10.1182/blood.V126.23.2946.2946
Published: 2015
Journal Articles

Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis

Simona Soverini, PhD, Caterina De Benedittis, PhD, Manuela Mancini, PhD, Michela Rondoni, MD, Cristina Papayannidis, MD PhD, Antonella Padella, Giorgina Specchia, Pr, MD, Roberta Zanotti, MD, Livio Pagano, Viviana Guadagnuolo, PhD, Maria Chiara Fontana, Massimo Delledonne, PhD, Alberto Ferrarini, PhD, Italo Do Valle, Daniel Remondini, PhD, Gastone Castellani, Raffaele Calogero, Serena Merante, MD, Chiara Elena, MD, Peter Valent, MD, Michele Cavo, Giovanni Martinelli, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4085.
https://doi.org/10.1182/blood.V126.23.4085.4085
Published: 2015
Journal Articles

BCR-ABL Mutations in Chronic Myeloid Leukemia (CML) Patients (pts) with Failure and Warning to First- and Second-Line Tyrosine Kinase Inhibitor (TKI) Therapy: What Is the Advantage of Next-Generation Sequencing (NGS) over Conventional Sequencing?

Simona Soverini, PhD, Caterina De Benedittis, PhD, Fausto Castagnetti, MDPhD, Gabriele Gugliotta, PhD, Manuela Mancini, PhD, Giorgina Specchia, Pr, MD, Domenico Russo, MD PhD, Alessandra Iurlo, MD PhD, Massimiliano Bonifacio, MD, Marzia Salvucci, Tamara Intermesoli, MD, Paolo Avanzini, MD, Sara Galimberti, MD, Bruno Martino, MD, Elena Maino, MD, Anna Rita Scortechini, MD, Katerina Machova Polakova, Giuseppe Saglio, Fabrizio Pane, MD, Gianantonio Rosti, MD, Michele Baccarani, Michele Cavo, MD, Giovanni Martinelli, MD PhD
Journal: Blood
Blood (2015) 126 (23): 346.
https://doi.org/10.1182/blood.V126.23.346.346
Published: 2015